OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
2.390
+0.130 (5.75%)
At close: Aug 29, 2025, 4:00 PM
2.330
-0.060 (-2.51%)
After-hours: Aug 29, 2025, 6:46 PM EDT

OS Therapies Statistics

Total Valuation

OS Therapies has a market cap or net worth of $76.22 million. The enterprise value is $67.79 million.

Market Cap76.22M
Enterprise Value 67.79M

Important Dates

The last earnings date was Monday, August 18, 2025, after market close.

Earnings Date Aug 18, 2025
Ex-Dividend Date n/a

Share Statistics

OS Therapies has 31.89 million shares outstanding. The number of shares has increased by 286.83% in one year.

Current Share Class 31.89M
Shares Outstanding 31.89M
Shares Change (YoY) +286.83%
Shares Change (QoQ) +18.19%
Owned by Insiders (%) 17.95%
Owned by Institutions (%) 0.72%
Float 23.37M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 13.56
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.03

Current Ratio 1.03
Quick Ratio 0.81
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -34.22

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -163.50%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -222.43%
Revenue Per Employee n/a
Profits Per Employee -$3.25M
Employee Count5
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.34% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -34.34%
50-Day Moving Average 1.88
200-Day Moving Average 2.15
Relative Strength Index (RSI) 60.81
Average Volume (20 Days) 768,844

Short Selling Information

The latest short interest is 667,159, so 2.09% of the outstanding shares have been sold short.

Short Interest 667,159
Short Previous Month 524,900
Short % of Shares Out 2.09%
Short % of Float 2.86%
Short Ratio (days to cover) 1.54

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -15.24M
Pretax Income n/a
Net Income -16.25M
EBITDA -15.13M
EBIT -15.24M
Earnings Per Share (EPS) -$0.74
Full Income Statement

Balance Sheet

The company has $2.80 million in cash and n/a in debt, giving a net cash position of $2.80 million or $0.09 per share.

Cash & Cash Equivalents 2.80M
Total Debt n/a
Net Cash 2.80M
Net Cash Per Share $0.09
Equity (Book Value) 6.75M
Book Value Per Share 0.17
Working Capital 95,942
Full Balance Sheet

Cash Flow

Operating Cash Flow -11.56M
Capital Expenditures n/a
Free Cash Flow -11.56M
FCF Per Share -$0.36
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

OS Therapies does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -286.83%
Shareholder Yield -286.83%
Earnings Yield -23.02%
FCF Yield -16.38%

Analyst Forecast

The average price target for OS Therapies is $18.00, which is 653.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target $18.00
Price Target Difference 653.14%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2